Detalhe da pesquisa
1.
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer.
Oncologist
; 28(10): e902-e909, 2023 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37141400
2.
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
Oncologist
; 23(11): 1271-e128, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30120161
3.
Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain.
Clin Transl Oncol
; 26(4): 864-871, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37651021
4.
Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study.
Cancers (Basel)
; 15(18)2023 Sep 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37760572
5.
Mitochondrial Function Differences between Tumor Tissue of Human Metastatic and Premetastatic CRC.
Biology (Basel)
; 11(2)2022 Feb 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35205159
6.
Inflammation- and Metastasis-Related Proteins Expression Changes in Early Stages in Tumor and Non-Tumor Adjacent Tissues of Colorectal Cancer Samples.
Cancers (Basel)
; 14(18)2022 Sep 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36139645
7.
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial.
Eur J Cancer
; 145: 158-167, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33485079
8.
Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol.
BMC Cancer
; 10: 528, 2010 Oct 05.
Artigo
Inglês
| MEDLINE | ID: mdl-20920369
9.
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease.
J Clin Med
; 9(12)2020 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33265959
10.
Antioxidant enzymes change in different non-metastatic stages in tumoral and peritumoral tissues of colorectal cancer.
Int J Biochem Cell Biol
; 120: 105698, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31981728
11.
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study.
Cancers (Basel)
; 12(8)2020 Aug 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32806731
12.
Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain / Estudio en el mundo real sobre patrones de prueba de inestabilidad de microsatélites y deficiencia de reparación de desajustes en pacientes con cáncer colorrectal metastásico en España
Clin. transl. oncol. (Print)
; 26(4): 864-871, Abr. 2024. tab
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-VR-49
13.
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
JCO Precis Oncol
; 3: 1-16, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35100697
14.
Non-tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response.
Free Radic Biol Med
; 126: 249-258, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30130568
15.
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
Neoplasia
; 20(7): 678-686, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29842993
16.
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Eur J Cancer
; 75: 73-82, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28222309
17.
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer.
Oncol Res
; 21(4): 181-91, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24762224
18.
Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.
Clin Transl Oncol
; 14(9): 689-97, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22855151